Latest in Drug Regulation & Safety in India

prnewswire.com
320 words

FDA approves Alhemo® injection as once-daily prophylactic treatment to prevent or reduce the frequency of bleeding episodes for adults and children 12 years of age and older with hemophilia A or B with inhibitors

Dec 20, 2024, 19:27 ET Alhemo® is designed to block a protein called TFPI in the body that stops blood from clotting. By blocking TFPI, Alhemo® improves the production of thrombin, a protein that helps to clot the blood and prevent bleeding, when…

Drug Regulation & Safety in India

India's drug regulators and medicine safety: CDSCO and the DCGI, state drug controllers, cough-syrup deaths, substandard and fake drugs, drug pricing.

  • 72 Tracked terms
  • Last 30 days Feed window

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

  • +32 more